SAN DIEGO, Jan. 10, 2024 Crinetics Pharmaceuticals, Inc. today announced that on January 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock.
Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, Jan. 03, 2024 Crinetics Pharmaceuticals, Inc. today announced that Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, will present at the 42nd Annual J.P..
Crinetics Announces Positive Initial Findings From Ongoing Open-Label Phase 2 Study Of Paltusotine For The Treatment Of Carcinoid Syndrome menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.